Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Clinical Proteomic Tumor Analysis Consortium, Joshua M. Wang, Runyu Hong, Elizabeth G. Demicco, Jimin Tan, Rossana Lazcano, Andre L. Moreira, Yize Li, Anna Calinawan, Narges Razavian, Tobias Schraink, Michael A. Gillette, Gilbert S. Omenn, Eunkyung An, Henry Rodriguez, Aristotelis Tsirigos, Kelly V. Ruggles, Li Ding, Ana I. Robles, D. R. ManiKarin D. Rodland, Alexander J. Lazar, Wenke Liu, David Fenyö, François Aguet, Yo Akiyama, Shankara Anand, Meenakshi Anurag, Özgün Babur, Jasmin Bavarva, Chet Birger, Michael J. Birrer, Lewis C. Cantley, Song Cao, Steven A. Carr, Michele Ceccarelli, Daniel W. Chan, Arul M. Chinnaiyan, Hanbyul Cho, Shrabanti Chowdhury, Marcin P. Cieslik, Karl R. Clauser, Antonio Colaprico, Daniel Cui Zhou, Felipe da Veiga Leprevost, Corbin Day, Saravana M. Dhanasekaran, Marcin J. Domagalski, Yongchao Dou, Brian J. Druker, Nathan Edwards, Matthew J. Ellis, Myvizhi Esai Selvan, Steven M. Foltz, Alicia Francis, Yifat Geffen, Gad Getz, Tania J. Gonzalez Robles, Sara J.C. Gosline, Zeynep H. Gümüş, David I. Heiman, Tara Hiltke, Galen Hostetter, Yingwei Hu, Chen Huang, Emily Huntsman, Antonio Iavarone, Eric J. Jaehnig, Scott D. Jewell, Jiayi Ji, Wen Jiang, Jared L. Johnson, Lizabeth Katsnelson, Karen A. Ketchum, Iga Kolodziejczak, Karsten Krug, Chandan Kumar-Sinha, Jonathan T. Lei, Wen Wei Liang, Yuxing Liao, Caleb M. Lindgren, Tao Liu, Weiping Ma, Fernanda Martins Rodrigues, Wilson McKerrow, Mehdi Mesri, Alexey I. Nesvizhskii, Chelsea J. Newton, Robert Oldroyd, Amanda G. Paulovich, Samuel H. Payne, Francesca Petralia, Pietro Pugliese, Boris Reva, Dmitry Rykunov, Shankha Satpathy, Sara R. Savage, Eric E. Schadt, Michael Schnaubelt, Stephan Schürer, Zhiao Shi, Richard D. Smith, Xiaoyu Song, Yizhe Song, Vasileios Stathias, Erik P. Storrs, Nadezhda V. Terekhanova, Ratna R. Thangudu, Mathangi Thiagarajan, Nicole Tignor, Liang Bo Wang, Pei Wang, Ying Wang, Bo Wen, Maciej Wiznerowicz, Yige Wu, Matthew A. Wyczalkowski, Lijun Yao, Tomer M. Yaron, Xinpei Yi, Bing Zhang, Hui Zhang, Qing Zhang, Xu Zhang, Zhen Zhang

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

We introduce a pioneering approach that integrates pathology imaging with transcriptomics and proteomics to identify predictive histology features associated with critical clinical outcomes in cancer. We utilize 2,755 H&E-stained histopathological slides from 657 patients across 6 cancer types from CPTAC. Our models effectively recapitulate distinctions readily made by human pathologists: tumor vs. normal (AUROC = 0.995) and tissue-of-origin (AUROC = 0.979). We further investigate predictive power on tasks not normally performed from H&E alone, including TP53 prediction and pathologic stage. Importantly, we describe predictive morphologies not previously utilized in a clinical setting. The incorporation of transcriptomics and proteomics identifies pathway-level signatures and cellular processes driving predictive histology features. Model generalizability and interpretability is confirmed using TCGA. We propose a classification system for these tasks, and suggest potential clinical applications for this integrated human and machine learning approach. A publicly available web-based platform implements these models.

Original languageEnglish
Article number101173
JournalCell Reports Medicine
Volume4
Issue number9
DOIs
StatePublished - Sep 19 2023

Keywords

  • CPTAC
  • cancer imaging
  • cancer proteogenomics
  • computational pathology
  • molecular diagnostics

Fingerprint

Dive into the research topics of 'Deep learning integrates histopathology and proteogenomics at a pan-cancer level'. Together they form a unique fingerprint.

Cite this